IO Biotech, Inc.
IOBT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $14 | $17 | $16 | $21 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $6 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $23 | $22 | $27 |
| Operating Income | -$19 | -$23 | -$23 | -$27 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $9 | -$3 | $0 | -$4 |
| Pre-Tax Income | -$10 | -$26 | -$22 | -$31 |
| Tax Expense | -$2 | $0 | $0 | $0 |
| Net Income | -$8 | -$26 | -$22 | -$31 |
| % Margin | – | – | – | – |
| EPS | -0.13 | -0.4 | -0.34 | -0.48 |
| % Growth | 67.5% | -17.6% | 29.2% | – |
| EPS Diluted | -0.13 | -0.4 | -0.34 | -0.48 |
| Weighted Avg Shares Out | 67 | 66 | 66 | 66 |
| Weighted Avg Shares Out Dil | 67 | 66 | 66 | 66 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $1 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$9 | -$26 | -$22 | -$31 |
| % Margin | – | – | – | – |